updates on teclistamab, talquetamab, and carvykti | mark wildgust, phd | ash 2022
Published 1 year ago • 1.4K plays • Length 5:29
Download video MP4
Download video MP3
Similar videos
-
9:33
talquetamab | ajai chari, md | ash 2022
-
14:31
teclistamab - guest lecture
-
2:27
mrd detection in blood | bruno paiva, phd | ash 2022
-
2:10
new developments at ash | rafat abonour, md | ash 2022
-
2:33
teclistamab approval for multiple myeloma treatment | ross firestone, md, phd | asco 2023
-
1:15
patient top concerns at and since diagnosis | nathan sweeney, phd | ash 2022
-
3:44
bispecific t cell engagers | noopur raje, md | ash 2022
-
4:39
car-t bms-986354 | luciano costa, md, phd | ash 2022
-
8:06
mezigdomide (cc-92480) | paul richardson, md | ash 2022
-
1:38
what to look forward to at ash | ola landgren, md, phd | ash 2022
-
17:55
talquetamab | therapies on the horizon
-
25:57
all about carvykti
-
22:21
tecvayli (teclistamab) everything you need to know
-
6:31
real-world results from talquetamab and bispecific antibodies | carolina schinke, md | ash 2023
-
3:11
bispecific antibodies | joshua richter, md | ash 2022
-
3:52
updates to management of car-t and teclistamab for myeloma patients | radhika bansal, md | ash 2023
-
1:46
how teclistamab treatment affects quality of life | rakesh popat, md | eha 2022
-
6:10
updated phase1b results for talquetamab in combination with daratumumab
Clip.africa.com - Privacy-policy